Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 9,681 | 9,355 | 8,309 | 6,426 | 6,264 |
| Operating Income | -9,681 | -9,355 | -8,309 | -6,426 | -6,264 |
| Other Income | 533 | 637 | 667 | 644 | 601 |
| Pre-tax Income | -9,148 | -8,718 | -7,642 | -5,782 | -5,663 |
| Net Income Continuous | -9,148 | -8,718 | -7,642 | -5,782 | -5,663 |
| Net Income | $-9,148 | $-8,718 | $-7,642 | $-5,782 | $-5,663 |
| EPS Basic Total Ops | -4.80 | -4.60 | -4.00 | 78.80 | -3.00 |
| EPS Basic Continuous Ops | -4.79 | -4.57 | -4.01 | 78.91 | -2.99 |
| EPS Diluted Total Ops | -4.80 | -4.60 | -4.00 | 78.80 | -3.00 |
| EPS Diluted Continuous Ops | -4.79 | -4.57 | -4.01 | 78.91 | -2.99 |
| EBITDA(a) | $-9,549 | $-9,366 | $-8,365 | $-6,506 | $-6,251 |